Joseph K. Belanoff took the long way back

Joseph K. Belanoff had four gray suits in his closet and a reason to wear them again. He had left Wall Street, gone back to school and begun an academic career. Business appeared to belong to an earlier version of his life. Then an idea from his research needed a company. The wardrobe, at least, was ready.

The detail is pleasingly practical. Founding stories usually acquire a garage, a napkin or a conveniently prophetic conversation. Belanoff’s includes clothes he already owned. He brought his old business experience to the task of raising venture capital, helping establish Corcept Therapeutics in 1998. Since 1999, he has served as its chief executive and a director. In 2014, he added the presidency.

His own recollection has a note of surprise: “I never thought I would return to doing business again once I had gotten into medical school.” The career he thought he had finished proved useful to the career he had chosen next. There is something reassuring about that. An abandoned profession can turn out to be an unusually thorough apprenticeship.

Nine years is a substantial detour

Belanoff graduated from Amherst College before spending nine years on Wall Street. His work involved fixed-income trading desks and interest-rate arbitrage programs at three securities firms. These were operating responsibilities, with the daily demands of markets attached. By the time he returned to formal education, he had already spent a substantial portion of his working life in finance.

Nine years deserves a moment on the page. The phrase “previously worked in finance” can make an entire first career sound like an internship. Belanoff’s earlier work included managing desks and programs across several firms. He subsequently earned his M.D. at Columbia University’s College of Physicians & Surgeons and completed residency training at Stanford. His route required becoming a student after becoming a manager.

That sequence gives the familiar idea of transferable skills some texture. A professional history does not arrive neatly sorted into skills that will be needed later and skills that can be discarded. Belanoff had experience running parts of a financial business before he had a reason to raise money for his own. The order only looks economical when the biography is read backward.

The degrees give this part of the story its institutional landmarks. Amherst supplied the undergraduate education; Columbia the subsequent professional degree; Stanford the residency and the academic affiliation. They also show that returning to education involved more than moving to a different office. There were new qualifications to earn before the next business venture came into view.

There is no need to give the younger Belanoff a secret master plan. The interesting part is the change in direction itself. Amherst, securities firms, Columbia and Stanford are distinct settings with distinct expectations. Moving between them meant accumulating experience in more than one professional language. Eventually, a founder would need to speak to both investors and academic collaborators.

A company adds another kind of responsibility

At Stanford, Belanoff worked with Alan F. Schatzberg. Their collaboration produced intellectual property, and Belanoff worried that licensing it to an established company could leave it unused. Building a business offered a way to take responsibility for what happened next. The decision connected an academic partnership with the financial experience he had acquired years earlier.

The dates keep the story honest. Corcept was incorporated in May 1998. Belanoff’s tenure as chief executive and director begins in 1999. Those are separate milestones: the establishment of the company and the beginning of his documented executive service. His subsequent career has extended through the considerable distance between organizing a young business and managing an established public one.

A founder has to give an idea somewhere to live. A chief executive has to keep the place running. The titles may sit beside each other in a biography, but they describe different obligations. Belanoff has retained both associations for more than a quarter of a century. The original decision to build something became a continuing commitment to its operation.

Wall Street, encountered from the other side

In April 2004, Corcept completed its initial public offering, selling 4.5 million shares and receiving approximately $49 million after underwriting discounts, commissions and estimated offering expenses. For someone whose first career had been in securities firms, a public listing made a particularly tidy turn in the plot. Finance had returned, this time around a company he helped create.

The accounting afterward is more revealing than the ceremony. By the end of 2006, approximately $39.6 million of those proceeds had gone toward research and development, with about $6.4 million used for general and administrative activities. Money raised had become money allocated. The company’s public record puts figures beside the less photogenic work of keeping an enterprise moving.

The public listing also supplies a clear date against which to measure the rest of the chronology. Twenty-two years separate that April 2004 offering from the company’s 2026 reporting year. The stretch is longer than the entire first career he brought to the venture. By then, running Corcept had become a much longer chapter than working on Wall Street.

It is tempting to let the flotation serve as the happy ending. In Belanoff’s case, it sits comparatively early in a long executive tenure. He continued as chief executive through the following two decades. Becoming president in 2014 added another title along the way. The larger story lies in the years of running the business after the shares began trading.

Getting the right people into one room

Belanoff’s work has also involved connecting people whose expertise sits outside the company. In an August 2023 investor conversation, he described an international network of roughly 35 to 40 academic collaborations at any given time. He also described a conference bringing collaborators together every four years. The purpose was to help people see how their separate work connected.

There is a wonderfully ordinary difficulty tucked into that account: participants could be unaware of what other collaborators were doing. A network can exist on an organizational chart while its members remain strangers to one another’s projects. Bringing everyone together addresses a problem that another announcement of a partnership cannot solve. Someone has to arrange the conversation.

That is an illuminating piece of the chief executive’s job. The founder who once had to explain an idea to investors was now explaining the relationships among many projects. In both cases, the work involved making connections intelligible. A collection of capable people needs occasions to compare what each has learned; a company needs a way to understand the collection.

There is a second obligation in this model: publishing results even when they are negative or mixed. Belanoff has made that expectation part of the company’s academic collaborations. As an operating principle, it gives disappointment a useful destination. Other people can learn from an unpromising result instead of spending their own time discovering the same obstacle.

“We really think very hard about what we can actually get done.”

Joseph K. Belanoff · 2021 investor call

The size of the job changes

By the second quarter of 2026, the business Belanoff led reported revenue of $256.1 million, compared with $194.4 million a year earlier. Net income was $43 million, and cash and investments totaled $544.6 million at June 30. The company raised its full-year revenue guidance to a range of $1.1 billion to $1.2 billion. Guidance describes an expectation; quarterly revenue records what has happened.

Those numbers help locate him in the present. An origin story can leave a founder permanently knocking on the first investor’s door. Belanoff’s current responsibilities belong to a business with substantial revenue, spending and resources to allocate. The question of how to organize people and money continues, with a different number of zeroes on the documents.

Leadership transitions are part of that work. In September 2026, Corcept announced that Justin Gunn would join the executive team and report to Belanoff, taking up his new responsibilities on October 1. Sean Maduck would remain as a senior commercial advisor. The arrangement placed an incoming leader and an experienced colleague in different roles during the handover.

A long-serving chief executive supplies continuity while colleagues’ responsibilities change around him. That can sound abstract until a dated announcement makes it concrete: one person assumes a job, another stays to advise, and the reporting line runs to the founder who has been there since the early years. Maintaining an organization means making room for those changes.

A life story, in his own voice

There is another way to encounter Belanoff beyond a corporate biography. His TEDxMontaVistaHighSchool talk, “My Life Story,” was published in November 2020. A separate BiotechTV interview appeared in May 2026. Together, the appearances offer a way to hear him speak at different points in a career often compressed into dates, degrees and executive titles.

The continuing academic connection adds another line to that chronology. Stanford lists him as an adjunct professor, while his company biography records positions at the university dating to 1992. The company and the university therefore remain parts of the same professional life. One chapter did not require every trace of the previous chapter to disappear.

His language about ambition can be measured. His 2021 investor remarks emphasized careful consideration of what the organization could accomplish. It is a useful sentence to keep beside the length of his tenure. Remaining in a job for decades brings repeated opportunities to discover the difference between an attractive possibility and an executable plan.

The lasting pleasure of Belanoff’s biography is its untidiness. A graduate spends nine years in markets, returns to school, joins an academic community and eventually resumes business in a different capacity. Years later, he is still running the company. Even the four gray suits have a role in the account. Sometimes a career change gives the things you kept a second purpose.